Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in ...

Medications like semaglutide and tirzepatide have gained significant attention for their impressive weight-loss effects, but they do much more than just helping you shed pounds. Let’s dive into ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Drugs in this class mimic a hormone the human body produces that increases insulin production, lowers blood sugar and reduces hunger.

If you’ve been taking Ozempic®, Wegovy®, or a compounded version of semaglutide, you might wonder, How long can you take semaglutide for weight loss? You can take semaglutide for weight loss ...